EBRD increases equity investment in Famar in Greece

Critical medicines: EU measures to boost competitiveness and tackle shortages 

This article is brought to you in association with EBRD. The European Bank for Reconstruction and Development (EBRD) is increasing its equity investment in Famar, a leading pharmaceutical contract development and manufacturing organisation headquartered in Greece.  The EBRD is committing an additional €5.2 million as part of a capital increase led by private equity firm MidEuropa, […]

Go back up